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ABSTRACT

METHODS

For patients with carotid artery disease who are at risk for traditional open surgery, a lessinvasive, clinically proven alternative called TCAR is available. This paper assesses whether
similar patients undergoing either TCAR or CEA have equivalent rates of postoperative
CVA, death, cranial nerve injury, and myocardial infarction (MI). This data is beneficial to
surgeons in order to evaluate the most effective therapeutic intervention in patients
presenting with carotid artery disease.

•

Step 1 : PubMed, EBSCO, and ClinicalKey were searched for studies comparing the
outcomes of patients with carotid artery disease who were treated with TCAR or CEA.

•

Step 2: Meta-analysis was conducted when appropriate.

•

Step 3: Using the three electronic databases mentioned above, the studies were selected
by searching the following key terms: “transcarotid artery revascularization, carotid
endarterectomy, safety, efficacy, versus, outcomes.”

•

Step 4: The search terms were then crossed and combined to perform a more advanced
search.

•

Step 5: From there, a detailed reading and critical analysis of each article were
performed. Duplicated articles were removed. Each study was classified based on its
study design (i.e., systematic reviews, case control, randomized control trials, cohort
studies, etc.) and methodological quality.

•

The literature searches from all three databases resulted in ten articles.

TCAR procedure. Savannah Vascular Institute.
https://www.savannahvascular.com/tcar-procedure/. Published June 12, 2019.
Accessed April 1, 2022.

BACKGROUND

LIMITATIONS AND DISCUSSIONS
•

Limitation 1: It is difficult to assess the comparison between TCAR and CEA because
most of the patients undergoing TCAR have underlying significant comorbidities such as
older age, underlying COPD, chronic kidney disease, and heart disease, which deny them
the option of CEA due to their poor surgical candidacy. Therefore, unless the patient
populations between the two groups are based on a 1:1 propensity matching, the results
are not as conclusive.

•

Limitation 2: Typically, TCAR is performed by vascular surgeons and success rates
could vary depending on the type of surgeon performing the operation. Of the studies
evaluated, no data was offered on a learning curve for TCAR.

•

Limitation 3: More data is needed in order to determine whether TCAR is effective on
standard-risk or low-risk patients. It is unreasonable to suggest that TCAR can be utilized
in all patients with carotid disease without studies representing all risk stratifications.¹

•

Limitation 4: The availability of CEA compared to TCAR is unequaled at this time. With
growing access to this novel modality, it could be reasonably suggested that the results
may change with better access, a better learning curve, and more experienced surgeons
performing TCAR.

•

Limitation 5: Confounding variables between the studies’ samples including hospital
resources, teaching affiliations, postoperative protocols, and other factors may need to be
considered when determining the validity of the various studies. 12
•

•

•

•

Stroke (CVA) is the fifth main cause of death and a major risk factor for long-term
disability.¹ Ischemic strokes are the most common type of strokes. Approximately thirty
percent of ischemic strokes are a result of atherosclerosis of the carotid arteries.¹ This
progressive buildup of plaque imposes a blockage in the carotid artery leading to the
brain. Risk factors for carotid artery stenosis include dyslipidemia, high blood pressure,
diabetes, obesity, cigarette smoking, family history, age, and lack of exercise.2 Medical
management and lifestyle changes may be initiated first. However, when arteriography
shows high-grade stenosis, consisting between 70-99% occlusion, operative treatments
such as an open surgical carotid endarterectomy (CEA) or endovascular intervention may
be recommended to mitigate the risk of an ipsilateral carotid stroke.
Current treatment options present problems of their own. CEA has been considered the
gold standard intervention for the treatment of carotid disease since the 1950’s, when it
was created by Dr. Michael DeBakey.4 Despite the fact that CEA is an accepted
intervention for patients with asymptomatic and symptomatic carotid artery stenosis, it
carries a 1-2% risk of permanent cranial nerve injury, 1-2% risk of postoperative neck
hematoma, and 2-6% risk of postoperative myocardial infarction, according to the 2010
CREST study.3
Recently, transcarotid artery revascularization (TCAR) was offered as a clinically proven,
less invasive alternative procedure to CEA. This novel carotid intervention may combine
the safety of a carotid endarterectomy with the lesser morbidity of a transfemoral carotid
stent and is aided by growing evidence of effectiveness in high-risk patients in need of
revascularization.7

Discussion 1: Another factor to consider is the cost-effectiveness of TCAR
compared to CEA. A recent study conducted by Cui et al.4 published in the
Journal of Vascular Surgery in December 2021 found that, although 5-year
costs for TCAR were $11,000 more than CEA, TCAR offered greater qualityadjusted life years (QALYs) and could be more economical in the long-term.4
These results were gathered from a high-volume institute for carotid
revascularization.4 More economic studies are needed to contrast the costeffectiveness of CEA and TCAR. Given the novelty of TCAR, it would be
reasonable to conclude that the cost of this intervention will decrease with
more wide-spread usage.

• Discussion 1: A study performed by Wang et al.15 consisted of 237 TCARs
executed at small, respected institutions. Of these cases, 55 stents were placed
because of restenosis (47 CEA, 8 transfemoral carotid artery stenting).15 Within
30 days of the operation, no additional CVAs or myocardial events occurred. In
addition, there were zero cases of in-stent restenosis, thrombosis, or reinterventions. The results concluded that TCAR has the potential to treat patients
with restenotic carotid disease with sustainable incidences of ipsilateral CVA,
myocardial infarct, and death.15
Carotid intervention: TCAR procedure benefits & recovery.
Silk Road Medical | Global website.
https://silkroadmed.com/patient-caregivers/tcar-benefitsrecovery/. Published October 29, 2020. Accessed April 1,
2022.

OBJECTIVES
•

•

Objective 1: This paper challenges the use of carotid endarterectomy (CEA), an invasive
vascular surgery, as a primary default to treating carotid stenosis by reviewing studies
involving transcarotid artery revascularization (TCAR), CEA, and their post-procedure
stroke, myocardial infarction, and cranial nerve injury rates.
Objective 2: This paper addresses the pathophysiology and risk factors of carotid artery
disease and the indications for intervention, whether it be TCAR or CEA.

•

Objective 3: This paper describes the perioperative steps during TCAR and CEA.

•

Objective 4: This paper compares operative times, perioperative blood loss, and
postoperative length of stay associated with CEA and TCAR.

•

Objective 5: This paper briefly reviews the cost-effectiveness of TCAR and CEA in relation
to long-term financial benefit for patients with minimal current data available.

RESULTS
•

Result 1: Inpatient and post-discharge myocardial infarction and CVA/death rates were
comparable between TCAR and CEA.1,6,7,8,11,12

•

Result 2: TCAR resulted in reduced risk of cranial nerve injuries compared to CEA in
multiple studies performed within the past decade.6,7,8,13

•

Result 3: TCAR is associated with less operative times and blood loss and shorter
postoperative length of stay.7,11,13

CONCLUSIONS
Transcarotid artery revascularization (TCAR) could present as a safer alternative to carotid
endarterectomy (CEA) for specific patients with high-level carotid artery stenosis. Further
comparative studies are warranted to confirm the similarity of TCAR vs CEA, with focus on
longer-term follow up and greater sample sizes.

References available upon request.

